Sox9 Is a Modifier of the Liver Disease Severity in a Mouse Model of Alagille Syndrome.


Journal

Hepatology (Baltimore, Md.)
ISSN: 1527-3350
Titre abrégé: Hepatology
Pays: United States
ID NLM: 8302946

Informations de publication

Date de publication:
04 2020
Historique:
received: 07 02 2019
accepted: 19 08 2019
pubmed: 31 8 2019
medline: 15 4 2021
entrez: 31 8 2019
Statut: ppublish

Résumé

Alagille syndrome (ALGS) is a multisystem developmental disorder characterized by bile duct (BD) paucity, caused primarily by haploinsufficiency of the Notch ligand jagged1. The course of the liver disease is highly variable in ALGS. However, the genetic basis for ALGS phenotypic variability is unknown. Previous studies have reported decreased expression of the transcription factor SOX9 (sex determining region Y-box 9) in late embryonic and neonatal livers of Jag1-deficient mice. Here, we investigated the effects of altering the Sox9 gene dosage on the severity of liver disease in an ALGS mouse model. Conditional removal of one copy of Sox9 in Jag1 Our results establish Sox9 as a dosage-sensitive modifier of Jag1

Sections du résumé

BACKGROUND AND AIMS
Alagille syndrome (ALGS) is a multisystem developmental disorder characterized by bile duct (BD) paucity, caused primarily by haploinsufficiency of the Notch ligand jagged1. The course of the liver disease is highly variable in ALGS. However, the genetic basis for ALGS phenotypic variability is unknown. Previous studies have reported decreased expression of the transcription factor SOX9 (sex determining region Y-box 9) in late embryonic and neonatal livers of Jag1-deficient mice. Here, we investigated the effects of altering the Sox9 gene dosage on the severity of liver disease in an ALGS mouse model.
APPROACH AND RESULTS
Conditional removal of one copy of Sox9 in Jag1
CONCLUSIONS
Our results establish Sox9 as a dosage-sensitive modifier of Jag1

Identifiants

pubmed: 31469182
doi: 10.1002/hep.30912
pmc: PMC7048647
mid: NIHMS1047972
doi:

Substances chimiques

Jag1 protein, mouse 0
Jagged-1 Protein 0
Receptors, Notch 0
SOX9 Transcription Factor 0
Sox9 protein, mouse 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1331-1349

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK107553
Pays : United States
Organisme : NIDDK NIH HHS
ID : DK56338
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK056338
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM130317
Pays : United States
Organisme : NIDDK NIH HHS
ID : DK078392
Pays : United States
Organisme : NICHD NIH HHS
ID : P50 HD103555
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK078392
Pays : United States
Organisme : NIDDK NIH HHS
ID : DK107553
Pays : United States
Organisme : NIDDK NIH HHS
ID : DK078640
Pays : United States
Organisme : NIGMS NIH HHS
ID : GM084135
Pays : United States
Organisme : NICHD NIH HHS
ID : U54 HD083092
Pays : United States
Organisme : NIDDK NIH HHS
ID : DK109982
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM084135
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK078640
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK109982
Pays : United States

Informations de copyright

© 2019 by the American Association for the Study of Liver Diseases.

Références

Hepatology. 2004 Jun;39(6):1739-45
pubmed: 15185318
Am J Pathol. 2007 Aug;171(2):641-53
pubmed: 17600123
Proc Natl Acad Sci U S A. 2016 Jun 14;113(24):E3384-93
pubmed: 27247392
Genes Dev. 2002 Nov 1;16(21):2813-28
pubmed: 12414734
J Pediatr. 1995 Aug;127(2):220-4
pubmed: 7636645
Hepatology. 2016 Jul;64(1):175-88
pubmed: 26926046
Microsc Res Tech. 1997 Nov 15;39(4):328-35
pubmed: 9407543
Hepatology. 2009 Sep;50(3):871-9
pubmed: 19551907
Am J Pathol. 2014 May;184(5):1479-88
pubmed: 24631193
Cell Mol Gastroenterol Hepatol. 2016 May 26;2(5):663-675.e2
pubmed: 28090565
Hepatology. 2013 Jun;57(6):2469-79
pubmed: 23315998
Hepatology. 2016 Feb;63(2):550-65
pubmed: 26235536
Nat Genet. 1997 Jul;16(3):235-42
pubmed: 9207787
Hepatology. 2016 Nov;64(5):1757-1772
pubmed: 27531557
J Pediatr. 1975 Jan;86(1):63-71
pubmed: 803282
Perspect Pediatr Pathol. 1991;14:122-42
pubmed: 2038546
Nat Genet. 1997 Jul;16(3):243-51
pubmed: 9207788
Hepatology. 2002 Oct;36(4 Pt 1):794-804
pubmed: 12297826
J Mt Sinai Hosp N Y. 1957 Sep-Oct;24(5):551-6
pubmed: 13476145
Development. 2009 May;136(10):1727-39
pubmed: 19369401
J Med Genet. 2012 Feb;49(2):138-44
pubmed: 22209762
Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6698-703
pubmed: 11371614
Gastroenterology. 2018 Mar;154(4):1080-1095
pubmed: 29162437
Hepatology. 1999 Mar;29(3):822-9
pubmed: 10051485
Hepatology. 2013 Apr;57(4):1607-19
pubmed: 23175466
Hum Mutat. 2006 May;27(5):436-43
pubmed: 16575836
Am J Hum Genet. 2006 Jul;79(1):169-73
pubmed: 16773578
Dev Cell. 2017 May 8;41(3):228-241
pubmed: 28486129
Curr Pathobiol Rep. 2017 Sep;5(3):233-241
pubmed: 29270332
Hepatology. 2015 Jun;61(6):2056-66
pubmed: 25572923
Development. 2002 Feb;129(4):1075-82
pubmed: 11861489
Curr Top Dev Biol. 2010;92:1-29
pubmed: 20816391
Liver Int. 2016 May;36(5):755-60
pubmed: 26201540
J Bone Miner Metab. 2011 Jan;29(1):123-9
pubmed: 20676705
Hum Mol Genet. 1999 May;8(5):723-30
pubmed: 10196361
J Pediatr Gastroenterol Nutr. 2010 May;50(5):526-30
pubmed: 20421762
Liver Transpl. 2009 Feb;15(2):177-83
pubmed: 19177433
Mol Cell Biol. 1988 Nov;8(11):4966-71
pubmed: 2905422
Am J Surg Pathol. 2005 Jun;29(6):820-6
pubmed: 15897750
Am J Hum Genet. 1998 Jun;62(6):1361-9
pubmed: 9585603
Virchows Arch. 2011 Mar;458(3):261-70
pubmed: 21298286
Nature. 1994 Dec 8;372(6506):525-30
pubmed: 7990924
Gastroenterology. 2009 Jun;136(7):2325-33
pubmed: 19403103
J Vis Exp. 2019 Apr 30;(146):
pubmed: 31107443
Nature. 2018 May;557(7704):247-251
pubmed: 29720662
Am J Pathol. 2000 May;156(5):1599-612
pubmed: 10793072
J Hepatol. 2002 Feb;36(2):200-9
pubmed: 11830331

Auteurs

Joshua M Adams (JM)

Program in Developmental Biology, Baylor College of Medicine, Houston, TX.
Medical Scientist Training Program, Baylor College of Medicine, Houston, TX.

Kari A Huppert (KA)

Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Eumenia C Castro (EC)

Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX.
Department of Pathology, Texas Children's Hospital, Houston, TX.

Mario F Lopez (MF)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.

Nima Niknejad (N)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.

Sanjay Subramanian (S)

Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.

Neda Zarrin-Khameh (N)

Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX.

Milton J Finegold (MJ)

Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX.

Stacey S Huppert (SS)

Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH.

Hamed Jafar-Nejad (H)

Program in Developmental Biology, Baylor College of Medicine, Houston, TX.
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH